270 related articles for article (PubMed ID: 14729457)
1. Inhibition of p38 mitogen-activated protein kinase reduces TNF-induced activation of NF-kappaB, elicits caspase activity, and enhances cytotoxicity.
Lüschen S; Scherer G; Ussat S; Ungefroren H; Adam-Klages S
Exp Cell Res; 2004 Feb; 293(2):196-206. PubMed ID: 14729457
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p38 kinase reveals a TNF-alpha-mediated, caspase-dependent, apoptotic death pathway in a human myelomonocyte cell line.
Varghese J; Chattopadhaya S; Sarin A
J Immunol; 2001 Jun; 166(11):6570-7. PubMed ID: 11359809
[TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
4. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
[TBL] [Abstract][Full Text] [Related]
5. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells.
Takada Y; Sethi G; Sung B; Aggarwal BB
Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248
[TBL] [Abstract][Full Text] [Related]
6. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
Zhang L; Himi T; Morita I; Murota S
Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.
Mohamed AA; Jupp OJ; Anderson HM; Littlejohn AF; Vandenabeele P; MacEwan DJ
Biochem J; 2002 Aug; 366(Pt 1):145-55. PubMed ID: 11996667
[TBL] [Abstract][Full Text] [Related]
9. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system.
Craig R; Larkin A; Mingo AM; Thuerauf DJ; Andrews C; McDonough PM; Glembotski CC
J Biol Chem; 2000 Aug; 275(31):23814-24. PubMed ID: 10781614
[TBL] [Abstract][Full Text] [Related]
10. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
[TBL] [Abstract][Full Text] [Related]
11. MKK6/3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression.
Fujishiro M; Gotoh Y; Katagiri H; Sakoda H; Ogihara T; Anai M; Onishi Y; Ono H; Funaki M; Inukai K; Fukushima Y; Kikuchi M; Oka Y; Asano T
J Biol Chem; 2001 Jun; 276(23):19800-6. PubMed ID: 11279172
[TBL] [Abstract][Full Text] [Related]
12. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
13. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
14. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L).
Grethe S; Ares MP; Andersson T; Pörn-Ares MI
Exp Cell Res; 2004 Aug; 298(2):632-42. PubMed ID: 15265709
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
16. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor.
Beyaert R; Cuenda A; Vanden Berghe W; Plaisance S; Lee JC; Haegeman G; Cohen P; Fiers W
EMBO J; 1996 Apr; 15(8):1914-23. PubMed ID: 8617238
[TBL] [Abstract][Full Text] [Related]
17. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils.
Wong CK; Zhang JP; Ip WK; Lam CW
Clin Exp Immunol; 2002 Jun; 128(3):483-9. PubMed ID: 12067303
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha induction of endothelial ephrin A1 expression is mediated by a p38 MAPK- and SAPK/JNK-dependent but nuclear factor-kappa B-independent mechanism.
Cheng N; Chen J
J Biol Chem; 2001 Apr; 276(17):13771-7. PubMed ID: 11278471
[TBL] [Abstract][Full Text] [Related]
19. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.
Chen CC; Sun YT; Chen JJ; Chang YJ
Mol Pharmacol; 2001 Mar; 59(3):493-500. PubMed ID: 11179444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
